Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-05-17
DOI
10.1161/circresaha.121.319077
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial
- (2020) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- Targeting Interleukin-1 and Interleukin-6
- (2020) Paul M Ridker JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-Inflammatory Therapy with Canakinumab for the Prevention of Hospitalization for Heart Failure
- (2019) Brendan M. Everett et al. CIRCULATION
- Anticytokine Agents
- (2019) Paul M Ridker CIRCULATION RESEARCH
- Immunotherapy for cardiovascular disease
- (2019) Esther Lutgens et al. EUROPEAN HEART JOURNAL
- The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study
- (2019) George Markousis‐Mavrogenis et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial
- (2019) Jon T. Giles et al. Arthritis & Rheumatology
- A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity
- (2019) Mickael Rosa et al. npj Genomic Medicine
- Genetic IL-6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis
- (2019) Alexander G. Bick et al. CIRCULATION
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 promotes a sustained loss of endothelial barrier function via Janus kinase-mediated STAT3 phosphorylation and de novo protein synthesis
- (2018) Hiba Alsaffar et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
- (2018) Paul M Ridker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels
- (2018) Daniel H. Solomon et al. ANNALS OF INTERNAL MEDICINE
- Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study
- (2018) Richard L. Amdur et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction
- (2018) Hilde E. Groot et al. Clinical Research in Cardiology
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update
- (2017) Hua Su et al. Frontiers in Immunology
- Interaction of IL-6 and TNF-α contributes to endothelial dysfunction in type 2 diabetic mouse hearts
- (2017) Jonghae Lee et al. PLoS One
- From C-Reactive Protein to Interleukin-6 to Interleukin-1
- (2016) Paul M Ridker CIRCULATION RESEARCH
- Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD
- (2016) J. Sun et al. Clinical Journal of the American Society of Nephrology
- Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
- (2016) Ola Kleveland et al. EUROPEAN HEART JOURNAL
- Targeting inflammation in diabetic kidney disease: early clinical trials
- (2016) Maria Vanessa Perez-Gomez et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction
- (2016) Michelle L. O’Donoghue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Test in Context
- (2016) Paul M Ridker JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- The NLRP3 inflammasome in kidney disease and autoimmunity
- (2016) Holly L Hutton et al. NEPHROLOGY
- Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion
- (2016) Minke H. T. Hartman et al. PLoS One
- Innate Immunity and the Failing Heart
- (2015) Douglas L. Mann CIRCULATION RESEARCH
- Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study
- (2014) Alexis Ogdie et al. ANNALS OF THE RHEUMATIC DISEASES
- Inflammation and Atherosclerosis
- (2014) Joshua Hartman et al. Cardiology in Review
- Association of IL-6 and a Functional Polymorphism in the IL-6 Gene with Cardiovascular Events in Patients with CKD
- (2014) B. Spoto et al. Clinical Journal of the American Society of Nephrology
- The emerging role of the inflammasome in kidney diseases
- (2014) Anthony Chang et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
- (2014) A. C. Morton et al. EUROPEAN HEART JOURNAL
- Administration of IL-1ra improves adiponectin levels in chronic hemodialysis patients
- (2014) Adriana M. Hung et al. JOURNAL OF NEPHROLOGY
- Serum amyloid A and inflammation in diabetic kidney disease and podocytes
- (2014) Robert J Anderberg et al. LABORATORY INVESTIGATION
- Interleukin-6 in renal disease and therapy
- (2014) S. A. Jones et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis
- (2013) Aart C. Strang et al. ATHEROSCLEROSIS
- Infusion of Pharmaceutical-Grade Natural Human C-Reactive Protein Is Not Proinflammatory in Healthy Adult Human Volunteers
- (2013) Thirusha Lane et al. CIRCULATION RESEARCH
- Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction
- (2013) Jean-Claude Tardif et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genome-wide Association and Population Genetic Analysis of C-Reactive Protein in African American and Hispanic American Women
- (2012) Alex P. Reiner et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
- (2012) Benjamin W. Van Tassell et al. PLoS One
- A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis
- (2011) A.D. Protogerou et al. ATHEROSCLEROSIS
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels
- (2011) Abbas Dehghan et al. CIRCULATION
- Endogenous Erythropoietin and the Association with Inflammation and Mortality in Diabetic Chronic Kidney Disease
- (2011) M. Wagner et al. Clinical Journal of the American Society of Nephrology
- Inflammation as a risk factor and target for therapy in chronic kidney disease
- (2011) Tetsu Miyamoto et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease
- (2011) Sundararaman Swaminathan et al. KIDNEY INTERNATIONAL
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
- (2011) E. Mezzaroma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
- (2010) Jodie L. Babitt et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice
- (2010) M. Kobara et al. CARDIOVASCULAR RESEARCH
- Inflammatory Markers and Incident Heart Failure Risk in Older Adults
- (2010) Andreas Kalogeropoulos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of LDL Cholesterol and Inflammation With Cardiovascular Events and Mortality in Hemodialysis Patients With Type 2 Diabetes Mellitus
- (2009) Vera Krane et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
- (2009) John J.V. McMurray et al. CIRCULATION
- Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease
- (2009) Daniela V. Barreto et al. KIDNEY INTERNATIONAL
- Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
- (2009) Shin-ya Kawashiri et al. RHEUMATOLOGY INTERNATIONAL
- Loci Related to Metabolic-Syndrome Pathways Including LEPR,HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study
- (2008) Paul M. Ridker et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER Study
- (2008) R. J. Glynn et al. CLINICAL CHEMISTRY
- Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
- (2008) Jeppe Zacho et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started